Bank Of America Corp My Md Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.22 - $0.58 $6,640 - $17,506	-30,184 Reduced 99.8%	59 $0
Q2 2023 Aug 14, 2023	BUY	$1.44 - $2.26 $348 - $546	242 Added 0.81%	30,243 $45,000
Q1 2023 May 12, 2023	SELL	$1.1 - $2.86 $8,539 - $22,202	-7,763 Reduced 20.56%	30,001 $51,000
Q4 2022 Feb 10, 2023	SELL	$0.92 - $96.0 $218 - $22,848	-238 Reduced 0.63%	37,764 $43,000
Q3 2022 Nov 14, 2022	BUY	$2.22 - $82.2 $17,762 - $657,682	8,001 Added 26.67%	38,002 $99,000
Q2 2022 Aug 12, 2022	SELL	$2.0 - $4.78 $340 - $812	-170 Reduced 0.56%	30,001 $65,000
Q1 2022 May 16, 2022	SELL	$3.34 - $6.05 $2,217 - $4,017	-664 Reduced 2.15%	30,171 $141,000
Q4 2021 Feb 08, 2022	BUY	$5.46 - $9.69 $86,453 - $153,431	15,834 Added 105.55%	30,835 $187,000
Q3 2021 Nov 15, 2021	BUY	$4.64 - $7.94 $46,330 - $79,280	9,985 Added 199.06%	15,001 $108,000
Q2 2021 Sep 13, 2021	BUY	$3.39 - $6.98 $17,004 - $35,011	5,016 New	5,016 $32,000

30.2K

Ticker MYMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,470,000
Market Cap $67.5M
Description
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.